No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Drug Manufacturers - Specialty & Generic
Headquartered in Seoul, South Korea, JW Pharmaceutical Corporation is a long-standing entity, established in 1945, specializing in the research, production, and global distribution of a comprehensive range of pharmaceuticals and medical supplies. The company's diverse product portfolio serves markets in Japan and numerous other international regions, addressing a broad spectrum of therapeutic areas including cardiovascular health, gastrointestinal and urinary conditions, central nervous system disorders, infectious diseases, women's health, kidney ailments, respiratory issues, oncology, pain management, and critical care nutrition.
www.jw-pharma.co.krNo one on the platform currently holds 001065.KS.
No tracked institution reports a position in 001065.KS as of their last filing.
No one on the platform has traded 001065.KS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 15.8% | 11.5% | — | — | — | |
| Rev. Growth % | 7.7% | 7.2% | ||||
| Profit Margin % | 8.0% | 5.3% | 1.8% | |||
| Free Cash Flow Margin % | 10.9% | 6.3% | 6.1% | |||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $849.2B | +7.6% | $3670.00 | $3670.00–$3670.00 | — | 1 |
| 2027 | $891.0B | +4.9% | $3982.00 | $3982.00–$3982.00 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| 001065.KSJW Pharmaceutical Corporation | $22350.00 | -0.22% | $394.3B | — |
| 000105.KSYuhan Corporation | $68200.00 | +0.59% | $5.93T | — |
| 001060.KSJW Pharmaceutical Corporation | $27100.00 | +0.00% | $625.8B | — |
| 001067.KSJW Pharmaceutical Corporation | $48350.00 | -0.10% | $447.2B | — |
| 007575.KSIlyang Pharmaceutical Co.,Ltd | $7540.00 | -0.13% | $154.0B | — |
| 019175.KSShinpoong Pharmaceutical Co.,Ltd | $14580.00 |
Source: Financial Modeling Prep · peers by sector/industry
| -3.76% |
| $386.3B |
| — |
| CGCCanopy Growth Corporation | $0.92 | -1.95% | $388M | — |